Risk for recurrence of papillary thyroid cancer may be identified through IHC using biologic markers, and may include the cancer stem cell marker CD133, although a clear role of CD133 in prognostication is not defined to date. Here, PROM1 is linked to thyroid gland papillary carcinoma.